A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia

An Open-label Multi-center Safety and Tolerability Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia & Healthy Volunteers

The purpose of the study is to evaluate the safety and tolerability of acupuncture for patients with BPSD & healthy volunteers.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This open label study is designed to evaluate the safety and tolerability of acupuncture as a intervention for patients with Behavioral and Psychological Symptoms of Dementia (BPSD)& healthy volunteers,and this study will enroll a total of 30(15 patients,15healthy volunteers) patients who are suffered from BPSD or healthy volunteers.The patients who have to be suitable for the standard of inclusion criteria will be included,and who have one condition of the exclusion criteria will be excluded,and so do the healthy volunteers.For each enrolled participant will obtain a baseline psychiatric and medical assessment, results of the Mini-Mental Status-Evaluation (MMSE),Behavioral Pathology in Alzheimer's Disease Rating Scale(BEHAVE-AD),Activity of Daily Living Scale(ADL)and other basic information prior to beginning acupuncture.For each participant will get acupuncture which once a day for 7 days running. During the trial the Questionnaire of Acupuncture-related Events have to be evaluated every day, and at the end of the intervention,all of the MMSE,BEHAV-AD,ADL and Treatment Emergent Symptom Scale (TESS)will be investigated.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610075
        • Yong Tang

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

The eligibility criteria of the patients arm:

Inclusion Criteria:

  1. patients who aged 60 to 85(inclusive) years
  2. The MMSE score of patients must be between 5 to 26
  3. Patients with diagnosis of Alzheimer's Disease according to DSM-Ⅳ(Diagnostic and Statistical Manual of Mental Disorders Fourth Edition)
  4. patients have one or more "target symptoms" of Behavioral and Psychological Symptoms of Dementia(BPSD) on the behavioral psychology in Alzheimer's disease rating scale (BEHAVE-AD),and the "target symptoms " of BEHAVE-AD have to have occurred nearly daily during the previous week or at least intermittently for 4 weeks
  5. Patients (or a legally acceptable representative)have signed the informed consent form

Exclusion Criteria:

  1. Received a diagnosis of a primary psychotic disorder (e.g.schizophrenia,bipolar disorder, severe or recurrent depression),other dementia such as vascular dementia,complex dementia or Lewy-body dementia,or psychosis,agitation, or aggression that could be better accounted for by another medical condition, or substance abuse
  2. Had severe system disease (e.g., cardiovascular, hepatorenal, hematopoietic system) or infectious disease
  3. Received medication (e.g.,benzodiazepines, antipsychotics, or anticholinergics)which could treat BPSD within 2 weeks prior to the first acupuncture of the study
  4. Participated in any clinical trial of drug within 4 weeks prior to the study
  5. History of taking acupuncture

The eligibility criteria of the healthy volunteers arm:

Inclusion Criteria:

  1. Healthy volunteers aged 60 to 85(inclusive) years who have provided written informed consent
  2. MMSE> or =27
  3. Have relative better health condition who do not suffered from severe system disease (e.g.,cardiovascular, hepatorenal, hematopoietic system) or infectious disease

Exclusion Criteria:

  1. History of significant neurological (including history of seizures,EEG abnormalities or dementia) or psychotic disorder (e.g.schizophrenia,bipolar disorder, severe or recurrent depression)
  2. History of drug or alcohol abuse
  3. History of taking medication that may be impair the function of cognition or psychotic behavior within 4 weeks before the study
  4. Participated in any clinical trial of drug within 4 weeks prior to the study
  5. History of taking acupuncture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy volunteers
Participators will be stimulated at specific acupuncture points as determined for the disease by the professional acupuncturists, and acupuncture once a day,last for one week.
Other Names:
  • Traditional Chinese Medicine
  • Complementary and Alternative Medicine
Experimental: Patients
Participators will be stimulated at specific acupuncture points as determined for the disease by the professional acupuncturists, and acupuncture once a day,last for one week.
Other Names:
  • Traditional Chinese Medicine
  • Complementary and Alternative Medicine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Questionnaire of Acupuncture Events
Time Frame: Every day during a 7 days trial
Every day during a 7 days trial

Secondary Outcome Measures

Outcome Measure
Time Frame
Change from baseline on Mini-Mental State-Examination(MMSE),The Behavioral Pathology in Alzheimer's Disease Rating Scale(BEHAVE-AD)and Activity of Daily Living Scale(ADL)
Time Frame: Baseline and 1week after the trial begen
Baseline and 1week after the trial begen
Treatment Emergent Symptom Scale (TESS)
Time Frame: Baseline and 2 weeks after the trial begen
Baseline and 2 weeks after the trial begen

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Yong Tang, M.D, Chengdu University of TCM

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

February 1, 2011

Study Completion (Actual)

March 1, 2011

Study Registration Dates

First Submitted

January 22, 2010

First Submitted That Met QC Criteria

January 22, 2010

First Posted (Estimate)

January 25, 2010

Study Record Updates

Last Update Posted (Estimate)

May 30, 2016

Last Update Submitted That Met QC Criteria

May 27, 2016

Last Verified

May 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Acupuncture

3
Subscribe